Suchergebnisse - "Roadcap, Brad"

PubPharm (20)

1

Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Phuah, J. | Maas, B. | Tang, A. | +10

2

Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data Analysis

enthalten in: The AAPS journal | 2022

von Xu, W. | Maas, B. | Roadcap, B. | +9

3

Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data Analysis

enthalten in: The AAPS journal | 2022

von Xu, W. | Maas, B. | Roadcap, B. | +9

4

Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data Analysis

enthalten in: AAPS PharmSci | 2022

von Xu, W. | Maas, B. | Roadcap, B. | +9

5

An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of Verubecestat

enthalten in: The AAPS journal | 2022

von Anderson, M. | Dockendorf, M. | McIntosh, I. | +10

6

An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of Verubecestat

enthalten in: The AAPS journal | 2022

von Anderson, M. | Dockendorf, M. | McIntosh, I. | +10

7

An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of Verubecestat

enthalten in: AAPS PharmSci | 2022

von Anderson, M. | Dockendorf, M. | McIntosh, I. | +10

8

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis

enthalten in: EBioMedicine | 2021

von Maas, B. | Lommerse, J. | Plock, N. | +25

9

A Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK-1654 in Healthy Adults

enthalten in: Clinical pharmacology in drug development | 2021

von Aliprantis, A. | Wolford, D. | Caro, L. | +12

10

Clinical application of volumetric absorptive microsampling to the gefapixant development program

enthalten in: Bioanalysis | 2020

von Roadcap, B. | Hussain, A. | Dreyer, D. | +8

ErratumIn: Bioanalysis. 2021 Mar;13(5):409. - PMID 33688751